These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 78704)

  • 1. Interaction of urokinase with alpha2-macroglobulin investigated by isoelectric focusing. Evidence for non-specific dissociable binding.
    Vahtera E; Hamberg U
    Biochem J; 1978 Jun; 171(3):767-70. PubMed ID: 78704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on cystic fibrosis using isoelectric focusing. II. Demonstration of deficient proteolytic cleavage of alpha2-macroglobulin in cystic fibrosis plasma.
    Wilson GB; Fudenberg HH
    Pediatr Res; 1976 Feb; 10(2):87-96. PubMed ID: 54896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical and chemical properties of human plasma alpha2-macroglobulin.
    Hall PK; Roberts RC
    Biochem J; 1978 Jul; 173(1):27-38. PubMed ID: 80217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of binding of pancreatic and urinary kallikreins to alpha 2-macroglobulin.
    Vahtera E; Hamberg U
    Biochem J; 1976 Aug; 157(2):521-4. PubMed ID: 61028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different molecular forms of plasminogen and plasmin produced by urokinase in human plasma and their relation to protease inhibitors and lysis of fibrinogen and fibrin.
    Müllertz S
    Biochem J; 1974 Nov; 143(2):273-83. PubMed ID: 4282470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and characterization of human kidney plasminogen activator dissimilar to urokinase.
    Sueishi K; Nanno S; Okamura T; Inoue S; Tanaka K
    Biochim Biophys Acta; 1982 Aug; 717(2):327-36. PubMed ID: 7052141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of urokinase to plasma proteinase inhibitors.
    Holmberg L; Lecander I; Astedt B
    Scand J Clin Lab Invest; 1980; 40(8):743-7. PubMed ID: 6169139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and some properties of urokinase.
    Ogawa N; Yamamoto H; Katamine T; Tajima H
    Thromb Diath Haemorrh; 1975 Sep; 34(1):194-209. PubMed ID: 242089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of alpha2-plasmin inhibitor on fibrin clot lysis. Its comparison with alpha2-macroglobulin.
    Aoki N; Moroi M; Tachiya K
    Thromb Haemost; 1978 Feb; 39(1):22-31. PubMed ID: 77050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural and functional characterization of the inhibition of urokinase by alpha 2-macroglobulin.
    Straight DL; Hassett MA; McKee PA
    Biochemistry; 1985 Jul; 24(15):3902-7. PubMed ID: 2413880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered isoelectric focusing of alpha 2-macroglobulin from plasma of patients with diabetes mellitus.
    Back SA; Lorenzi M; Alhadeff JA
    Clin Chim Acta; 1985 Jul; 150(1):21-9. PubMed ID: 2412734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated human plasma carboxypeptidase B is retained in the blood by binding to alpha2-macroglobulin and pregnancy zone protein.
    Valnickova Z; Thogersen IB; Christensen S; Chu CT; Pizzo SV; Enghild JJ
    J Biol Chem; 1996 May; 271(22):12937-43. PubMed ID: 8662763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma inhibitors of the components of the fibrinolytic pathway in man.
    Schreiber AD; Kaplan AP; Austen KF
    J Clin Invest; 1973 Jun; 52(6):1394-401. PubMed ID: 4122174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of porcine alpha2-macroglobulin with chemically modified proteinases.
    Tsuru D; Kado K; Fujiwara K; Tmimatsu M; Ogita K
    J Biochem; 1978 May; 83(5):1345-53. PubMed ID: 659400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-amyloid peptide binds equivalently to binary and ternary alpha2-macroglobulin-protease complexes.
    Mettenburg JM; Gonias SL
    Protein J; 2005 Feb; 24(2):89-93. PubMed ID: 16003950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The properties of rabbit alpha1-macroglobulin upon activation are distinct from those of rabbit and human alpha2-macroglobulins.
    Banbula A; Chang LS; Beyer WF; Bohra CL; Cianciolo GJ; Pizzo SV
    J Biochem; 2005 Nov; 138(5):527-37. PubMed ID: 16272565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bait region cleavage and complex formation of human alpha2M with a Porphyromonas gingivalis W50 protease is not accompanied by enzyme inhibition.
    Rangarajan M; Scragg MA; Curtis MA
    Biol Chem; 2000 Jan; 381(1):57-65. PubMed ID: 10722051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the interaction between alpha2-macroglobulin and fibroblast growth factor-2: the role of hydrophobic interactions.
    Mathew S; Arandjelovic S; Beyer WF; Gonias SL; Pizzo SV
    Biochem J; 2003 Aug; 374(Pt 1):123-9. PubMed ID: 12755687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of urokinase by complex formation with human alpha1-antitrypsin.
    Clemmensen I; Christensen F
    Biochim Biophys Acta; 1976 Apr; 429(2):591-9. PubMed ID: 1083251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a new alpha-2-macroglobulin: Multi-spectroscopic and isothermal titration calorimetry study.
    Rehman AA; Ahsan H; Khan FH
    Int J Biol Macromol; 2016 Feb; 83():366-75. PubMed ID: 26608004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.